Ton Dang

Nhà nghiên cứu Hồ sơ 6/10

32 công bố · 406 trích dẫn · h-index 8

Thông tin

🏛️Nơi công tác: Học viện Quân y
🔬Lĩnh vực: Y - Dược
🆔ORCID: 0000-0003-0035-2746
✍️Hồ sơ chưa đầy đủ — bổ sung thông tin

Chỉ số h-index 8 xếp học giả này vào lĩnh vực Y - Dược, thuộc nhóm 25% dẫn đầu trong 6.619 hồ sơ cùng lĩnh vực của danh bạ này.

Công bố tiêu biểu

Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study151 trích dẫn
PLoS ONE · 2016 · DOI

A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease77 trích dẫn
PLoS ONE · 2014 · DOI

IL-17–Secreting γδ T Cells Are Completely Dependent upon CCR6 for Homing to Inflamed Skin54 trích dẫn
The Journal of Immunology · 2017 · DOI

CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the Blood29 trích dẫn
The Journal of Immunology · 2019 · DOI

Efficacy of Chemokine Receptor Inhibition in Treating IL-36α–Induced Psoriasiform Inflammation25 trích dẫn
The Journal of Immunology · 2019 · DOI

CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS)15 trích dẫn
PLoS ONE · 2018 · DOI

Immature dendritic cells expressing indoleamine 2,3-dioxygenase suppress ovalbumin-induced allergic airway inflammation in mice.12 trích dẫn
PubMed · 2011

Abstract 5655: Inhibition of CCR2 potentiates checkpoint inhibitor immunotherapy in murine model of pancreatic cancer11 trích dẫn
Cancer Research · 2017 · DOI

Correction: Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study7 trích dẫn
PLoS ONE · 2019 · DOI

CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity7 trích dẫn
PLoS ONE · 2023 · DOI

Về lĩnh vực Y - Dược

6.619học giả

91.896công bố

2.589.484trích dẫn

4.2h-index trung bình

Hướng nghiên cứu phổ biến trong lĩnh vực:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Nơi có nhiều học giả lĩnh vực này nhất: